Dr Colin Reveley, one of our Daphne Jackson Fellows, is developing MRI techniques to investigate the structure of grey matter in the brain. This could help diagnose dementia sooner and identify those most at risk earlier in life.
Dr Colin Reveley, one of our Daphne Jackson Fellows, is developing MRI techniques to investigate the structure of grey matter in the brain. This could help diagnose dementia sooner and identify those most at risk earlier in life.
We are the first partner to join the Royal Society on their Career Development Fellowship, working together to fund a dementia researcher from Black heritage.
We are the first partner to join the Royal Society on their Career Development Fellowship, working together to fund a dementia researcher from Black heritage.
Prof Nathan Davies was funded by Alzheimer’s Society as a junior fellow early in his career. Now, as Co-Director of the Doctoral Training Centre for Integrated Dementia Care, he's inspiring the next generation of dementia researchers.
Prof Nathan Davies was funded by Alzheimer’s Society as a junior fellow early in his career. Now, as Co-Director of the Doctoral Training Centre for Integrated Dementia Care, he's inspiring the next generation of dementia researchers.
After real-world testing in an outpatient cognitive service, a new protocol shows how an accelerated procedure can cut scan time without compromising diagnostic utility.
After real-world testing in an outpatient cognitive service, a new protocol shows how an accelerated procedure can cut scan time without compromising diagnostic utility.
During his DRL Fellowship (2025–29), Professor Dave Cash hopes to make dementia clinical trials cheaper and faster. This would reduce the time to identify successful drugs, enabling patients to get access to effective drugs earlier.
During his DRL Fellowship (2025–29), Professor Dave Cash hopes to make dementia clinical trials cheaper and faster. This would reduce the time to identify successful drugs, enabling patients to get access to effective drugs earlier.
Supporting researchers to advance diagnosis, understand causes, develop new treatments and inform clinical practices to ensure the best care for people living with dementia.
Supporting researchers to advance diagnosis, understand causes, develop new treatments and inform clinical practices to ensure the best care for people living with dementia.
Alzheimer’s Society is bringing you highlights from the International Society for Frontotemporal Dementias (ISFTD) Conference, which was held in Amsterdam, Netherlands in late September.
Alzheimer’s Society is bringing you highlights from the International Society for Frontotemporal Dementias (ISFTD) Conference, which was held in Amsterdam, Netherlands in late September.